Our researchers have produced a paper detailing the nanoparticle formulation of a highly insoluble drug compound, niclosamide, with known anti SARS-CoV-2 activity as a cheap and scalable long-acting injectable antiviral candidate. pubs.rsc.org/en/Content/Art… #longactingtherapeutics

For more papers like this one visit our publications page where we have an archive of all #longactingtherapeutics papers written by CELT scientists... 👉liverpool.ac.uk/centre-of-exce…

📨📨📨You can now sign up to our mailing list to receive the latest news, updates and events information from CELT📨📨📨 Follow the link to register 👉liverpool.ac.uk/centre-of-exce… #longactingtherapeutics

Congratulations to our brilliant colleague Usman Arshad who has passed his viva for his PhD thesis entitled 'Nanoparticle Interventions for Colorectal Cancer Liver Metastases: Optimisation of Irinotecan Therapy'. Well-deserved recognition for his incredible hard work. 👏👏👏

Find out about #LONGEVITY - our ambitious project developing the long acting pipeline to establish medicines for malaria, TB and hepatitis C virus with infrastructure for sustainable translational capacity. 👉liverpool.ac.uk/centre-of-exce… #longactingtherapeutics Funded by Unitaid 🤝

📰CELT researchers demonstrate the nanoparticle formulation of niclosamide, a highly insoluble drug compound, as a scalable long-acting injectable antiviral candidate. Read the full news item here 👉news.liverpool.ac.uk/2021/04/14/lon… #longactingtherapeutics

In case you missed it: CELT researchers demonstrate the nanoparticle formulation of niclosamide, a highly insoluble drug compound, as a scalable long-acting injectable antiviral candidate. Read the full news item here 👉 news.liverpool.ac.uk/2021/04/14/lon… #longactingtherapeutics

📨📨📨Keep up to date with CELT news, projects and research developments by subscribing to our mailing list to receive regular news updates straight to your inbox📨📨📨 Sign up here 👉 liverpool.ac.uk/centre-of-exce…

Our friends over at Treatment Action Group (TAG) and AFROCAB-HIV| Afrocab Treatment Access Partnership are excited to share a call for a new long-acting technologies community advisory board focused on malaria, HCV, and latent TB infection. If you are interested visit their website for more info👉 hepcoalition.org/news/article/c…

If you work in the field of #nanotherapeutics or have a related project, you could work with our Nanotherapeutics Hub and benefit from our analytical expertise and links to partner institutions to support your development. Find out more 👉 liverpool.ac.uk/centre-of-exce…

💻> Register to World Health Organization (WHO) Unitaid MedicinesPatentPool online session on #HepC treatment for #LMICs during #WHA74! ✅Latest tools & publications from World Health Organization (WHO) Unitaid ✅Feedback from #Rwanda ✅Panel discussion w/countries & experts ⏰Wednesday 26 May, 1-2pm CET 👉 bit.ly/2Sz1ia8

The Nanotehrapeutics Hub at CELT has joined forces with iiCON: Infection Innovation Consortium to support companies looking to develop cutting-edge nanotherapeutics to combat infectious diseases and access the nanomedicine market. Find out more 👉 liverpool.ac.uk/centre-of-exce… #nanotherapeutics #infectioninnovation

Brilliant collaborative effort involving CELT researchers investigating novel nanoparticle vaccination approaches for #COVID19 resulting in an enhanced and protective response in mice. Great work from all involved! Read the full paper here 👉 biorxiv.org/content/10.110… #covidvaccine

Visit our 'About Us' page to learn more about the centre, including our mission statement, what we value most in our research, our most critical challenges and how we will overcome them. 👉 ow.ly/qUuk50FigrD #longacting #pharmacology #chemistry #longactingtherapeutics

The AGILE (AGILE) Platform allows us to test new #COVID19 treatments faster than ever before with the aim to find affordable drugs which can be accessed by communities globally. 🎞️Watch our infographic to find out more 👉youtube.com/watch?v=bgXEOn… LSTM, Southampton CTU

📰 Evaluation of intranasal nafamostat or camostat for SARS-CoV-2 chemoprophylaxis in Syrian golden hamsters Read the full preprint 👉 ow.ly/eLqM50Fsmqy James Stewart 🦠🌿 Andrew Owen

New research from CELT Pharmacology University of Liverpool Engineering and Physical Sciences Research Council in collaboration with Unitaid Upperton Pharma Solutions: “Long-Acting #Injectable #Medicine as Potential Route to #COVID-19 Therapy”. Explore their project page hubs.ly/H0TFGwp0

Today is #InternationalYouthDay! In 2017 children under five accounted for 61% of #malaria deaths worldwide. The #LONGEVITY project aims to tackle the issue of non-adherence and control of the disease to drastically reduce these statistics. 👉ow.ly/Mktx50FPxoA

🔎 Find out about #LONGEVITY - our ambitious project designed to develop #longacting drug formulations for; ✔️ #malaria prevention ✔️ #tb prevention ✔️ a single-injection cure for #hepatitisC 👉ow.ly/hXGY50G8ORb Funded by Unitaid 🤝

💡 The #LONGEVITY project aims to be transformational for healthcare provision in low and middle-income countries by developing #longacting formulations to drastically reduce the burden #malaria, #tb and #hepatitisC imposes on those communities. 👉ow.ly/hXGY50G8ORb